Earth Science Tech, Inc.

ETST ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Operating Activities
Net Income $3.6M $3.3M $812.1K $-365.4K $3.2M $-4.4M $-1.2M $-2.2M
Depreciation & Amortization $284.4K $151.7K $149.7K $17.5K — $2.4K $7.2K $11.5K
Depreciation $219.9K $44.0K $34.4K $6.9K $0 — — —
Amortization — — — $13.8K — — — $4.4K
Stock-Based Compensation — — $300 $4.5K — — $142.6K $448.1K
Net Cash from Operating Activities $1.9M $4.4M $1.2M $-1.0M $-168.1K $-196.7K $-518.6K $-1.6M
Investing Activities
Capital Expenditures $756.6K $753.2K $26.5K — — — — —
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities $-1.9M $-1.9M $-26.5K — $1.7K — — —
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases $471.4K $1.5M $178.0K — — — — —
Net Cash from Financing Activities $-712.9K $-1.7M $-517.9K $1.0M $173.2K $182.1K $421.8K $1.7M
Net Change in Cash $-676.4K $775.5K $661.8K $3.4K $6.8K $-14.6K $-96.8K $55.5K
Free Cash Flow $1.2M $3.6M $1.2M — — — — —
← Newer Page 1 of 2 Older →